rimcazole has been researched along with bd 1047 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appleyard, MV; Box, G; Campbell, LA; Cooper, MA; Downes, CP; Eccles, S; Ferguson, MJ; Hayes, A; Howie, J; Lambert, JJ; Leslie, NR; McLean, D; McTavish, N; Murray, K; Nutley, B; O'Neill, M; Peters, JA; Prescott, AR; Raynaud, F; Safrany, ST; Samson, J; Spruce, BA; Thompson, AM; Watt, S | 1 |
Duncan, G; Prescott, AR; Sanderson, J; Spruce, BA; Wang, L | 1 |
Dhir, A; Kulkarni, SK | 2 |
4 other study(ies) available for rimcazole and bd 1047
Article | Year |
---|---|
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium Signaling; Carbazoles; Caspases; Cattle; Cell Division; Cell Line, Tumor; Enzyme Activation; Ethylenediamines; Haloperidol; Humans; Isoenzymes; Lung Neoplasms; Male; Mice; Mice, Nude; Phospholipase C delta; Piperazines; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, sigma; Sigma-1 Receptor; Type C Phospholipases; Xenograft Model Antitumor Assays | 2004 |
Sigma receptor antagonists inhibit human lens cell growth and induce pigmentation.
Topics: Blotting, Western; Carbazoles; Cell Proliferation; Cells, Cultured; Epithelial Cells; Ethylenediamines; Humans; Intramolecular Oxidoreductases; Lens, Crystalline; Melanins; Membrane Glycoproteins; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Oxidoreductases; Pigmentation; Receptors, sigma; Reverse Transcriptase Polymerase Chain Reaction; Sigma-1 Receptor; Tyrosine | 2005 |
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Carbazoles; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Receptors, sigma; Sigma-1 Receptor; Swimming; Venlafaxine Hydrochloride | 2007 |
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bupropion; Carbazoles; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Progesterone; Receptors, sigma; Sigma-1 Receptor; Stress, Psychological | 2008 |